Thomas Livinghouse advances small‑molecule antimicrobials at the interface of chemistry and microbiology. He holds an issued patent on autoinducer compounds and a $568,569 grant in stereoselective heterocycle synthesis. Publications highlight prodrug strategies active against biofilms and planktonic bacteria.